4//SEC Filing
KEEGAN JOSEPH D 4
Accession 0001415889-22-010914
CIK 0000842023other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 5:19 PM ET
Size
13.5 KB
Accession
0001415889-22-010914
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
KEEGAN JOSEPH D
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-10-27+865→ 865 totalExercise: $295.77Exp: 2032-10-27→ Common Stock (865 underlying) - Award
Common Stock
2022-10-27+338→ 2,671 total
Holdings
- 3,125
Stock Options (Right to Buy)
Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying) - 2,011
Stock Options (Right to Buy)
Exercise: $201.64From: 2020-10-24Exp: 2029-10-24→ Common Stock (2,011 underlying) - 1,898
Stock Options (Right to Buy)
Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Common Stock (1,898 underlying) - 1,507
Stock Options (Right to Buy)
Exercise: $255.69From: 2021-10-28Exp: 2030-10-29→ Common Stock (1,507 underlying) - 633
Stock Options (Right to Buy)
Exercise: $515.24From: 2022-10-27Exp: 2031-10-28→ Common Stock (633 underlying)
Footnotes (1)
- [F1]This option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001260556
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 5:19 PM ET
- Size
- 13.5 KB